Meet the Precision AQ
Team at the
2025 AVBCC Summit

Our market access agency empowers oncology clients by delivering stage, line of therapy, and indication specific strategies tailored to the evolving landscape of cancer care. With deep expertise in regulatory, clinical, and commercial domains, and a team that includes former FDA reviewers, oncology pharmacists, and access decision-makers, we help clients navigate complex challenges like buy-and-bill models, specialty distribution, and reimbursement dynamics. Our proprietary network of experts from 100+ leading cancer centers ensures real-time insights and precision-driven strategies that optimize access and accelerate success from development through commercialization.

We equip pharma access teams by transforming fragmented payer, provider, and patient data into actionable insights that drive smarter strategy and execution. With deep expertise and purpose-built tools, they help pharma teams anticipate coverage shifts, identify access barriers, and tailor messaging to key stakeholders, ultimately improving payer engagement and patient access. Their structured data hierarchies, intuitive dashboards, and real-time analytics empower clients to make confident decisions across the commercialization journey.

Our access consulting services guide you through complex payer landscapes to optimize pricing and reimbursement strategies. From early planning to post-launch, we connect you with key stakeholders to accelerate patient access and drive sustained commercial success.

Uncover the access barriers influencing oncologists’ prescribing decisions with OncoGenius Access Insights. Our solutions provide actionable intelligence into formularies, EHR treatment plans, and pathways for your product across 100+ top US Cancer Centers. Insights are informed by a panel of oncology pharmacy experts from leading academic and community institutions, including NCCN and NCI centers, ensuring insights from the most sophisticated oncology environments.